Fabrice Chouraqui
Net worth: 162 673 $ as of 29/09/2026
Net worth: 162 673 $ as of 29/09/2026
Dr. Fabrice Chouraqui is an Independent Member-Governors Board at Orano Med Manufacturing SAS. He is on the Board of Directors at Orano Med Manufacturing SAS. Dr. Chouraqui was previously employed as a Chief Executive Officer & Executive Director by Pharming Group NV, a President by Novartis Pharmaceuticals Corp., and a Chief Executive Officer & Director by Cellarity Inc. He received his graduate degree from Universite Paris Cite, an MBA from INSEAD and a doctorate degree from Universite Paris Cite.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHARMING GROUP NV 0.02% | 30/03/2026 | 161,425 ( 0.02% ) | 162 673 $ | 29/09/2026 |
| Companies | Position | Start |
|---|---|---|
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| PHARMING GROUP N.V. | Chief Executive Officer | 28/09/2026 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | President | 31/12/2018 |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Chief Executive Officer | 11/05/2025 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
Select your edition
All financial news and data tailored to specific country editions